How long do weight loss injections last — and what happens when you stop?

The myth: a few months of injections and you're done

The most common misconception our prescribers hear is that weight loss injections are a short, finite course, like antibiotics, take them for eight weeks, reach your target, stop. In practice, that framing doesn't match how these medicines work or what the research shows. Tirzepatide and semaglutide work by activating gut-hormone receptors that suppress appetite and slow how quickly food leaves your stomach. That effect is present while the medicine is in your system. When you stop, the receptors return to their baseline state, and for many people so does appetite.

A follow-up study of the STEP 1 trial (the pivotal semaglutide 2.4mg trial published in the New England Journal of Medicine) tracked participants for a year after they stopped treatment. On average, roughly two-thirds of the weight lost during the 68-week trial was regained within that single year off treatment. This isn't a failure of the medicine; it reflects that obesity is a long-term condition with a biological basis, not a temporary state corrected by a short intervention. You can read more about the underlying mechanisms on the how weight loss injections work page.

Understanding this early shapes more realistic expectations. It also changes the question from "how long will I need to take it?" to "how do I use this time well?" The clinical trials ran for 68 to 72 weeks precisely because sustained results require sustained treatment, alongside meaningful changes to diet and activity.

How long each dose lasts in your body

Both tirzepatide and semaglutide have pharmacokinetic profiles designed for once-weekly dosing. The half-life of tirzepatide is approximately five days; semaglutide's is approximately seven days. In practical terms, medicine levels in your bloodstream remain therapeutically active across the full seven-day window between injections, which is why missing a dose by several days can result in a noticeable return of appetite before the next pen is due.

Treatment typically begins at a low starter dose (2.5mg for tirzepatide) because the first pen's purpose is to let your system adjust, not to deliver the full therapeutic effect. Dose increases happen at intervals set by your prescriber, generally around every four weeks, climbing toward a maintenance dose based on your individual response and tolerability. The timeline for when the injections start working is a separate question, but the short answer is that noticeable appetite suppression usually arrives before the first significant weight movement does.

Storage matters across the whole treatment period. Each pen needs to be kept refrigerated (most people settle it in the fridge door next to everyday items rather than somewhere they'd forget it) though your Patient Information Leaflet sets out the precise room-temperature window if you need to travel. The full guide to weight loss injections covers storage, injection technique and what to expect from each pen in more detail.

What duration of treatment looks like in practice

NICE's appraisal of tirzepatide (TA1026) was informed by trial data running to 72 weeks, and the NHS's own commissioning guidance is built around that evidence base. For private patients, there is no fixed upper limit set by a regulator, but that doesn't mean treatment is indefinite by default. A prescriber reviews the picture at every repeat: is weight loss progressing? Are any concerns emerging? Is the dose still appropriate? At nume (sorry, at our pharmacy) every repeat order is clinically re-reviewed by a real prescriber, not processed automatically.

NICE guidance suggests that if a patient has not achieved at least five per cent weight loss after six months on the highest tolerated dose, continuing treatment should be reviewed. That threshold gives both patient and prescriber a concrete checkpoint. For people who do respond well, treatment may continue for considerably longer, with the goal of sustaining weight reduction while lifestyle habits take hold. More detail on what clinical outcomes typically look like is on the does the weight loss injection actually work page.

If you're weighing up the financial side of longer-term treatment, the weight loss injection prices page sets out what a legitimate private prescription typically costs and what an all-in price should include.

After stopping: what the evidence says about weight regain

Post-treatment weight regain is not a fringe concern, it is documented in multiple published trials. The STEP 1 follow-up data mentioned above is the most cited example, but similar patterns appear in the SURMOUNT trial programme. The implication is not that treatment is pointless; rather, it confirms that sustained benefit requires either continued treatment or a genuine shift in underlying habits, ideally both. Some people use the treatment period deliberately, treating it as a window to embed new eating patterns and activity levels that can support weight maintenance after stopping. Others continue treatment long-term under prescriber supervision.

What does not work is assuming a short course resolves the problem permanently. The detailed page on how long the effects last after stopping walks through the post-trial data and what it means for planning. For a broader look at all the treatment options available, the weight management overview is a useful starting point. And if you want to understand how quickly results tend to appear before thinking about duration, the speed of effect page addresses that directly.

These are prescription-only medicines. Deciding on treatment length, and whether to continue or stop, is a conversation with your prescriber, not something to determine from a guide alone. If you have questions our team hasn't answered yet, the FAQs page covers the questions we hear most often, or you can get in touch directly. When you're ready to take the next step, a free consultation with one of our GPhC-registered prescribers is the right place to start.